Efficient nonviral gene delivery into primary lymphocytes from rats and mice
- PMID: 16401643
- DOI: 10.1096/fj.05-4651fje
Efficient nonviral gene delivery into primary lymphocytes from rats and mice
Abstract
A rapid method for efficient gene delivery into primary rodent lymphocytes would greatly facilitate the study of signaling and metabolic pathways in untransformed hematopoietic cells as well as the validation of gene expression and targeting strategies before the generation of knockout or knock-down animals. Here, we report that species-adapted nucleofection procedures combined with optimized cultivation conditions render proliferating primary T cells, B cells, and natural killer cells from widely used rat and mouse strains susceptible to high-level gene delivery. As a result, transgene expression levels were enhanced approximately 10- to 370-fold over established protocols. The effectiveness of the nucleofection approach for functional analyses was demonstrated by specific down-regulation of CD4 cell surface molecules by either transient expression of the endocytosis-inducing Nef protein from human immunodeficiency virus or by specific gene silencing mediated by small interfering RNA. In conclusion, this species-adapted procedure for nonviral gene delivery renders primary rodent lymphocytes accessible to rapid functional ex vivo studies, which until now have not been feasible. Furthermore, nucleofection may aid the advancement of therapeutic nonviral gene delivery approaches.
Comment in
-
Non-viral gene delivery into primary natural killer lymphocytes.FASEB J. 2006 Dec;20(14):2660. doi: 10.1096/fj.06-1204ufm. FASEB J. 2006. PMID: 17142802 No abstract available.
Similar articles
-
High-level transfection of primary rabbit T lymphocytes.J Immunol Methods. 2008 Jul 20;336(1):85-9. doi: 10.1016/j.jim.2008.03.006. Epub 2008 Apr 7. J Immunol Methods. 2008. PMID: 18471825
-
Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.Gene Ther. 1996 Jun;3(6):521-30. Gene Ther. 1996. PMID: 8789802
-
siRNA stabilization prolongs gene knockdown in primary T lymphocytes.Eur J Immunol. 2008 Sep;38(9):2616-25. doi: 10.1002/eji.200738075. Eur J Immunol. 2008. PMID: 18792414
-
The mechanism of naked DNA uptake and expression.Adv Genet. 2005;54:3-20. doi: 10.1016/S0065-2660(05)54001-X. Adv Genet. 2005. PMID: 16096005 Review.
-
Nonviral vectors for the delivery of small interfering RNAs to the CNS.Nanomedicine (Lond). 2010 Oct;5(8):1219-36. doi: 10.2217/nnm.10.105. Nanomedicine (Lond). 2010. PMID: 21039199 Review.
Cited by
-
HIV-susceptible transgenic rats allow rapid preclinical testing of antiviral compounds targeting virus entry or reverse transcription.Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):1015-20. doi: 10.1073/pnas.0607414104. Epub 2007 Jan 5. Proc Natl Acad Sci U S A. 2007. PMID: 17209012 Free PMC article.
-
Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses.J Virol. 2010 Nov;84(21):11374-84. doi: 10.1128/JVI.01067-10. Epub 2010 Aug 11. J Virol. 2010. PMID: 20702620 Free PMC article.
-
T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice.Cell. 2008 Aug 22;134(4):577-86. doi: 10.1016/j.cell.2008.06.034. Epub 2008 Aug 7. Cell. 2008. PMID: 18691745 Free PMC article.
-
Novel protein transduction domain mimics as nonviral delivery vectors for siRNA targeting NOTCH1 in primary human T cells.Mol Ther. 2013 Jan;21(1):201-9. doi: 10.1038/mt.2012.209. Epub 2012 Oct 16. Mol Ther. 2013. PMID: 23070119 Free PMC article.
-
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs.Mol Ther. 2021 Nov 3;29(11):3293-3304. doi: 10.1016/j.ymthe.2021.06.004. Epub 2021 Jun 4. Mol Ther. 2021. PMID: 34091054 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials